Trial Runners Revenue and Competitors

Dickinson, ND USA

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Trial Runners's estimated annual revenue is currently $2.1M per year.(i)
  • Trial Runners's estimated revenue per employee is $71,400

Employee Data

  • Trial Runners has 29 Employees.(i)
  • Trial Runners grew their employee count by -12% last year.

Trial Runners's People

NameTitleEmail/Phone
1
President & CEOReveal Email/Phone
2
VP Clinical OperationsReveal Email/Phone
3
Director Continuous Improvement & Organizational OperationsReveal Email/Phone
4
Director Clinical OperationsReveal Email/Phone
5
Director Marketing And Business DevelopmentReveal Email/Phone
6
Project ManagerReveal Email/Phone
7
Project Manager IIReveal Email/Phone
8
Project ManagerReveal Email/Phone
9
Clinical Project ManagerReveal Email/Phone
10
Clinical Project Manager (Australia)Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.1M29-12%N/AN/A
#2
$27.7M2477%N/AN/A
#3
$17.6M1572%N/AN/A
Add Company

What Is Trial Runners?

Trial Runners is an ophthalmology CRO providing biotech and pharmaceutical companies with clinical research management services. Since 2006, we have worked on over 70 clinical studies researching innovative ways to manage or cure diseases related to the eye. Our mission is to provide an unprecedented level of execution, commitment and value. Our history of working in clinical ophthalmology with faithful adherence to our mission statement has made the quality of service Trial Runners provides its clients the best in the industry. Our time-proven resolve to continue on this path of excellence will result in Trial Runners being the #1 Ophthalmology CRO.

keywords:N/A

N/A

Total Funding

29

Number of Employees

$2.1M

Revenue (est)

-12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.9M30-9%N/A
#2
$6.7M310%N/A
#3
$6.5M33-3%N/A
#4
$1.7M373%N/A
#5
$7M405%N/A